Insights

Market commentary and guides

  • XJO & Market Direction

    To discuss the implementation of our index trades either in CFDs, futures or other ASX instruments, please call the office on 1300 614 002.…

  • Lendlease: Is it a value trap?

    We begin a closer look at Lendlease as an out-of-cycle recovery play and ask the question, value trap or plain value? FY22 Financial &…

  • We are buying this ETF…

    1/12 update: IAA has rallied as expected. iShares Asia 50 The fund aims to provide investors with the performance of the S&P Asia 50TM…

  • Fisher & Paykel Healthcare: Earnings

    Fisher & Paykel Healthcare Corporation expects group revenue to be higher in 2H than 1H due to historical hospital sales seasonality and destocking momentum.…

  • XJO & Market Direction

    To discuss the implementation of our index trades either in CFDs, futures or other ASX instruments, please call the office on 1300 614 002.…

  • US Equities: Valuation Analysis

    The market is at a valuation level where we’ll need to see evidence of earnings stabilizing, and forecasts being upgraded. The December numbers will…

  • We are buying this ETF…

    iShares Asia 50 The fund aims to provide investors with the performance of the S&P Asia 50TM Index, beforefees and expenses. The index is…

  • Emerging Markets

    Vanguard FTSE Emerging Markets Shares offers long-term value.

  • Brambles – Algo Buy

    24/11 update: Brambles continues to find buying support. 14/11: BXB will likely form a higher low above the recent $10.88 pivot low. Watch the…

  • Xero

    Xero is looking oversold and the chart pattern to watch is highlighted below.